Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung ...

LOS ANGELES, CA, USA I August 12, 2025 I Abcentra LLC, a clinical-stage biopharmaceutical company pioneering targeted therapies for cardiovascular ...

HUNTINGTON, NY, USA I August 12, 2025 I Sen-Jam Pharmaceutical today announced significant progress in advancing its innovative immuno-regulator platform ...

SEOUL, South Korea I August 13, 2025 I Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) and Daewoong Therapeutics (CEO Bok-Ki Kang) ...

New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates ...

SOUTH SAN FRANCISCO, CA, USA I August 12, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...

SCHLIEREN/ZURICH, Switzerland I August 12, 2025 I Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived ...

BASEL, Switzerland I August 12, 2025 I Novartis today announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus ...

CUMBERLAND, RI, USA I August 11, 2025 I Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic ...

SHANGHAI, China I August 11, 2025 I On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a ...

FORT LEE, NJ, USA I August 11, 2025 I Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of ...

NEW YORK, NY, USA I August 11, 2025 I Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough ...